215 related articles for article (PubMed ID: 23398860)
1. [Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population].
García-Rodríguez J; Cantón E; Pemán J; Alvarez M; Ezpeleta G; Gómez-Nieto A; Iglesias I; Martín-Mazuelos E; Ramírez-de Ocariz I; Rezusta A; Royo-García G;
Enferm Infecc Microbiol Clin; 2013; 31(6):363-8. PubMed ID: 23398860
[TBL] [Abstract][Full Text] [Related]
2. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
3. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.
Martí-Carrizosa M; Sánchez-Reus F; March F; Coll P
Scand J Infect Dis; 2014 Jun; 46(6):454-61. PubMed ID: 24762093
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
6. Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010.
Dzierzanowska-Fangrat K; Romanowska E; Gryniewicz-Kwiatkowska O; Migdał M; Witulska K; Ryżko J; Kaliciński P; Książyk J; Nadkowska P; Dzierzanowska D
Mycoses; 2014 Feb; 57(2):105-9. PubMed ID: 23834472
[TBL] [Abstract][Full Text] [Related]
7. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
[TBL] [Abstract][Full Text] [Related]
8. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.
Chen PL; Lo HJ; Wu CJ; Lee HC; Chang CM; Lee NY; Wang AH; Lin WL; Ko NY; Lee CC; Ko WC
Mycoses; 2011 Jul; 54(4):e17-23. PubMed ID: 20028463
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
[TBL] [Abstract][Full Text] [Related]
12. Candidaemia in Sweden: a nationwide prospective observational survey.
Ericsson J; Chryssanthou E; Klingspor L; Johansson AG; Ljungman P; Svensson E; Sjölin J
Clin Microbiol Infect; 2013 Apr; 19(4):E218-21. PubMed ID: 23331511
[TBL] [Abstract][Full Text] [Related]
13. [Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].
Pemán J; Cantón E; Miñana JJ; Florez JA; Echeverria J; Ortega DN; Alarcón JM; Fontanals D; Sard BG; Moreno BB; Torroba L; Ayats J; Pérez MÁ; Fernández MA; Reus FS; Natal IF; García GR; Ezpeleta G; Martín-Mazuelos E; Iglesias I; Rezusta A; de Ocariz IR; Nieto AG;
Rev Iberoam Micol; 2011; 28(2):91-9. PubMed ID: 21376831
[TBL] [Abstract][Full Text] [Related]
14. An investigation of Candida species isolated from blood cultures during 17 years in a university hospital.
Kazak E; Akın H; Ener B; Sığırlı D; Özkan Ö; Gürcüoğlu E; Yılmaz E; Çelebi S; Akçağlar S; Akalın H
Mycoses; 2014 Oct; 57(10):623-9. PubMed ID: 24934185
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of candidaemia and invasive candidiasis. A changing face.
Quindós G
Rev Iberoam Micol; 2014; 31(1):42-8. PubMed ID: 24270071
[TBL] [Abstract][Full Text] [Related]
18. Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain.
Rodríguez D; Almirante B; Cuenca-Estrella M; Rodríguez-Tudela JL; Mensa J; Ayats J; Sanchez F; Pahissa A;
Clin Microbiol Infect; 2010 Nov; 16(11):1676-82. PubMed ID: 20219079
[TBL] [Abstract][Full Text] [Related]
19. Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan.
Lai CC; Chu CC; Wang CY; Tsai HY; Cheng A; Lee YC; Huang YT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2012 Oct; 40(4):349-53. PubMed ID: 22819796
[TBL] [Abstract][Full Text] [Related]
20. Candidaemia due to Candida parapsilosis species complex at a hospital in Brazil: Clinical characteristics and antifungal susceptibility profile.
Alencar DSO; Tsujisaki RAS; Spositto FLE; Nunes MO; Almeida AA; Martins MDA; Melhem MSC; Chang MR
Rev Iberoam Micol; 2017; 34(2):106-108. PubMed ID: 28214273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
